コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 c-Jun and activating transcription factor 2 (ATF2).
2 tion of an AP1 complex (containing c-Jun and ATF2).
3 phospho-CREB and cytoplasmic accumulation of ATF2.
4 inhibited JNK activity via competition with ATF2.
5 or ATP and noncompetitive inhibition against ATF2.
6 l of the basic region leucine zipper protein ATF2.
7 targets the transcription factors c-Jun and ATF2.
8 ased levels of the histone acetyltransferase ATF2.
9 ncluding the transcription factors c-Jun and ATF2.
10 and requires transcription factors c-Jun and ATF2.
11 phosphorylation of the transcription factor ATF2.
12 y blocked by ATF2DeltaN, a dominant negative ATF2.
13 t binds transcription factors c-Jun and CREB/ATF2.
14 de derived from amino acid (aa) 51 to 100 of ATF2.
15 ion of the AP-1-related transcription factor ATF2.
16 vated protein (MAP) kinase and its substrate ATF2.
17 yclase, ADCY8, and the transcription factor, ATF2.
18 horylation and transcriptional activation of ATF2.
19 , a transcription factor homologous to human ATF2.
20 r63 and Ser73 of c-Jun or Thr69 and Thr71 of ATF2.
21 lates and activates the transcription factor ATF2.
22 IL-23p19 indirectly, likely via reduction of ATF2.
23 y regulates the transcriptional potential of ATF2.
24 effectively influenced protein expression of ATF2.
25 is maintained through the JNK activation of ATF2.
26 ed on the delta-domain sites of JIP ( 3) and ATF2 ( 1) were not recognized by p38, also of the MAPK f
29 and requires amino acids 150 to 248 of ATF2 (ATF2(150-248)), which are implicated in intramolecular i
34 Mutations within the JNK binding region of ATF2(50-100) or expression of TAM67 or JunD RNAi attenua
36 s sensitization of melanoma cells expressing ATF2(50-100) to apoptosis after treatment with anisomyci
37 and B16F10 mouse melanomas were inhibited by ATF2(50-100) to varying degrees up to a complete regress
38 peptide spanning amino acids 50-100 of ATF2 (ATF2(50-100)) reduces ATF2 transcriptional activities wh
42 ed (+/-250 bp) with RUNX3 (64%), BATF (55%), ATF2 (51%), IRF4 (41%), MEF2A (35%), PAX5 (34%), SPI1 (2
52 nt with this concept, the phosphorylation of ATF2 along with the expression and phosphorylation of c-
53 se in transcriptional activity by endogenous ATF2 and a markedly increased sensitivity to the four ag
54 peptide outcompeted TIP49b interaction with ATF2 and alleviated the suppression of ATF2 transcriptio
55 c-MYC induces stress-mediated activation of ATF2 and ATF7 and that these transcription factors regul
57 ism for JNK1beta1 with transcription factors ATF2 and c-Jun along with interaction kinetics for these
60 Together, these findings demonstrate that ATF2 and c-Jun mutually regulate each other by altering
61 immunoprecipitation with antibodies against ATF2 and c-Jun or their phosphorylated forms and hybridi
63 nse occurs at least partly via activation of ATF2 and c-Jun, leading to large-scale coordinate gene e
64 e affinity of unphosphorylated JNK1beta1 for ATF2 and c-Jun, to 0.80 +/- 0.04 versus 0.65 +/- 0.07 mu
70 ssion of the downstream transcription factor ATF2 and completely blocked by ATF2DeltaN, a dominant ne
71 on leads to the decreased phosphorylation of ATF2 and consequent increased expression of the melanocy
72 or-activated receptor-gamma accompanied with ATF2 and CREB (cAMP-response element-binding protein) wa
77 c-Jun in the nucleus prevents the export of ATF2 and is essential for the transcriptional activation
78 symmetrically located amino acid residues in ATF2 and Jun facilitated the interactions between hetero
81 on and Mkk4(-/-) ESCs exhibited diminished p-ATF2 and MEF2C expression, resulting in impaired MHC ind
82 creased expression of c-JUN was dependent on ATF2 and on activation of the MEK-ERK and JNK arms of th
83 perturbation resulted in the accumulation of ATF2 and RNF20 and the promiscuous accumulation of DDR-a
85 ctly upregulating gene expression (c-fos and ATF2) and by activating pathways that stimulate AP-1 act
86 oteins (c-Jun dimerization protein 2 [JDP2], ATF2, and histone deacetylase 6 [HDAC6]), as determined
89 causes activation of calcineurin (Cn), NFAT, ATF2, and NFkappaB/Rel factors, which collectively alter
90 hat cAMP acts through the PKA/CREB, PKA/PI3K/ATF2, and PKA/ERK/ATF2 pathways to control a key vascula
94 Although it has been believed that c-Jun and ATF2 are constitutively localized in the nucleus, where
95 ansport (e.g. QDR2, YBT1), lipid metabolism (ATF2, ARE1), cell stress (HSP12, CTA1), DNA repair (YIM1
96 -driven mouse B-cell lymphomas, we find that ATF2 as well as MAP kinase c-Jun N-terminal kinase (JNK)
99 ndent and requires amino acids 150 to 248 of ATF2 (ATF2(150-248)), which are implicated in intramolec
100 of a peptide spanning amino acids 50-100 of ATF2 (ATF2(50-100)) reduces ATF2 transcriptional activit
105 d kinase inhibitors down-regulated Thr(P)-71-ATF2 binding to the il23a promoter and il23a mRNA expres
110 l mobility shift assays revealed that mainly ATF2 bound to this CRE-like element, and mutation of the
111 dose- and time-dependent phosphorylation of ATF2 by ATM that results in its rapid colocalization wit
112 rylations on N-terminal Thr-71 and Thr-69 of ATF2 by ERK and p38 MAPK, MEK, and p38 MAPK inhibitors b
113 ivation of nuclear factor-kappaB, c-jun, and ATF2 by TNF was comparable in HUAECs and HUVECs, whereas
114 ylated rapidly and this methylation inhibits ATF2/c-Jun and CREB transcription factor binding in vitr
119 t or -deficient cells and requires the Smad1-Atf2 complex that facilitates their recruitment to the p
121 like the yeast GCN4, and the mammalian JUN, ATF2, CREB, C/EBP, and PAR leucine zippers, characterize
122 that control mitochondrial function, such as ATF2, CREB, PGC1alpha, DIO2, NRF1, CYTC, COX2, ATP5beta,
126 insight into regulation of ATM activation by ATF2-dependent control of TIP60 stability and activity.
127 st explained through coordinated kappaB- and ATF2-dependent transcription; and (iii) il23a expression
130 ly, stable expression of a dominant negative ATF2 (dnATF2) quantitatively blocks phosphorylation of e
133 toxic stress attenuates PKCepsilon effect on ATF2; enables ATF2 nuclear export and localization at th
137 anoma, we evaluated the pattern and level of ATF2 expression in a large cohort of melanoma specimens.
139 elanoma and prostate cancer cell lines whose ATF2 expression is inversely correlated with TIP60 level
143 However, activating transcription factor-2 (ATF2) expression was significantly lower in CD8(+) compa
144 nt with these findings, keratinocytes of K14.ATF2(f/f) mice exhibit greater anchorage-independent gro
146 2-tetradecanoate 13-acetate (DMBA/TPA)], K14.ATF2(f/f) mice showed significant increases in both the
147 expressed ATF2 mutant with K14-Cre mice (K14.ATF2(f/f)) resulted in selective expression of mutant AT
149 duced p19 promoter activation, and c-Jun and ATF2 formed a protein complex, demonstrated by co-immuno
150 ATF2 and FoxP3 reveals an important role of ATF2-FoxP3 pathway in the anisomycin-induced apoptosis o
151 CREB) and activating transcription factor 2 (ATF2), function as a transcriptional activator and a rep
152 sistent with this, both Gal4-c-Jun- and Gal4-ATF2-fusion proteins were activated by RalA signalling t
153 on factor activating transcription factor 2 (ATF2) has been shown to be associated with melanocytic o
160 e CREB or a constitutively nuclear-localized ATF2 in LNCaP cells inhibits IR-induced NE-like differen
164 d transformation and reveal a novel role for ATF2 in the inhibition of the Ras-Raf-MEK-ERK signaling
165 nditions, activating transcription factor-2 (ATF2) in cooperation with Cul3 ubiquitin ligase promotes
166 ctions of activating transcription factor-2 (ATF2) in the development and therapeutic resistance of m
167 vealed a positive feedback mechanism whereby ATF2 induces p38 MAPK phosphorylation to further induce
169 in consisting of HIV-TAT and aa 51 to 100 of ATF2 into SW1 melanomas efficiently inhibits their growt
174 l findings in which transcriptionally active ATF2 is involved in tumor progression-proliferation in m
180 ermed ATF2 deletion (ATF2d), encodes a novel ATF2 isoform and was chosen for further characterization
188 increased after AA limitation, and c-JUN or ATF2 knockdown suppressed the induction of c-JUN and oth
190 atively blocks phosphorylation of endogenous ATF2 leading to a marked decrease in transcriptional act
193 t transcription required the presence of the ATF2-like AP1-site at -70 bp and the c-Jun binding motif
196 ere is a sub-population of Her2(+)p-p38(lo)p-Atf2(lo)Twist1(hi)E-cad(lo) early cancer cells that is i
197 ein kinase C-varepsilon (PKCvarepsilon)- and ATF2-mediated mechanism that facilitates resistance by t
198 f PKCvarepsilon with chemotherapies relieves ATF2-mediated transcriptional repression of IFNbeta1, re
203 In addition, a phosphorylation-negative ATF2 mutant construct decreased basal and TGFbeta-mediat
205 ors, JUN, activating transcription factor 2 (ATF2), myocyte-specific enhancer factor 2A (MEF2A), and
208 PKCepsilon, as seen in melanoma cells, block ATF2 nuclear export and function at the mitochondria, th
209 ttenuates PKCepsilon effect on ATF2; enables ATF2 nuclear export and localization at the mitochondria
211 0-248) in fibroblasts or melanoma but not in ATF2-null cells caused a profound G(2)M arrest and incre
213 tly, c-Jun-dependent nuclear localization of ATF2 occurs during retinoic acid-induced differentiation
215 e that the protein kinase ATM phosphorylates ATF2 on serines 490 and 498 following ionizing radiation
216 n relies on complementary phosphorylation of ATF2 on Thr-69 and Thr-71 dependent on PKC and MAPK acti
219 expression of a dominant-negative mutant of ATF2 or expression of an ATF2-specific short hairpin RNA
223 hese results, overexpression of c-Jun, ATF1, ATF2, or CREB1 in transiently transfected osteoblastic c
224 nhibition, whereas transfection of Creb1 and Atf2 overexpression constructs enhanced cAMP-driven Cd39
225 g viral-mediated gene transfer, we show that ATF2 overexpression in nucleus accumbens produces increa
227 morphogenetic protein-Smad1 and Atm-p38MAPK-Atf2 pathways in p53-proficient or -deficient cells and
228 ugh the PKA/CREB, PKA/PI3K/ATF2, and PKA/ERK/ATF2 pathways to control a key vascular homeostatic medi
229 mechanisms underlying the activities of the ATF2 peptide while highlighting its possible use in drug
231 rom the phosphoacceptor activation domain on ATF2 (peptides 4 and 5) were recognized neither as subst
232 he first time in VSMC that TGFbeta activates ATF2 phosphorylation and Csrp2 gene expression via a CRE
233 tivation of p38 kinase, all of which induced ATF2 phosphorylation and increased TIP49b-ATF2 associati
234 TA treatment resulted in an increase in ATF2 phosphorylation, which was followed by a subsequent
236 c-Jun and activating transcription factor-2 (ATF2) phosphorylation and binding to the PI.3/PII region
237 dicate that JNK-dependent phosphorylation of ATF2 plays an important role in the drug resistance phen
240 factor IRF3, and activator of transcription ATF2, reaching levels similar to those seen in C(ko) vir
246 lts suggest that cytoplasmic localization of ATF2 requires function of at least one of the NESs.
249 H(2)-terminal kinase with c-Jun but not with ATF2, resulting in concomitant increase in TRE-mediated
250 a peptide that corresponds to aa 51 to 60 of ATF2 sensitizes melanoma cells to spontaneous apoptosis,
251 led the induction was mediated by a p38-MAPK-ATF2 signaling pathway and that RNAi-mediated inhibition
254 -negative mutant of ATF2 or expression of an ATF2-specific short hairpin RNA interfered with TRPM3-me
255 had both weak cytoplasmic and strong nuclear ATF2 staining had the worst outcome, both among the full
256 their transcription factor effectors (c-Jun, ATF2, Stat3 and NF-kappaB) affects TNF, Fas and TRAIL re
258 cancer cells, suggesting that alteration of ATF2 subcellular localization may be involved in the pat
259 d further understanding of the regulation of ATF2 subcellular localization under various pathological
261 sphorylation by MKK6, kinase activity toward ATF2 substrate, thermal stability, and X-ray crystal str
262 ir transcription factor substrates c-Jun and ATF2, suggesting that D-site-containing substrates also
263 NES enhances the transcriptional activity of ATF2, suggesting that the novel NES negatively regulates
264 d JNK2-mediated phosphorylation of c-Jun and ATF2, suggesting that transcription factors, MKK4, and t
265 Furthermore, co-transfection of c-Jun and ATF2 synergistically induced p19 promoter activation, an
267 is associated with transgenic insertion into Atf2, the gene for the basic leucine zipper (bZIP) trans
268 the phosphorylation of CREB1 (Ser(133)) and ATF2 (Thr(71)) in a PKA-, PI3K-, and ERK-dependent fashi
269 of CREB, transcription factor 1 (ATF1), and ATF2, three transcription factors that bind to the cycli
270 a shift in the K(D) of the active kinase for ATF2 to 1.70 +/- 0.25 muM and for c-Jun of 3.50 +/- 0.95
271 ta1 decreased the affinity of the kinase for ATF2 to 11.0 +/- 1.1 muM and for c-Jun to 17.0 +/- 7.5 m
272 ted that binding of phosphorylated CREB1 and ATF2 to cAMP-response element-like sites was significant
274 F2(50-100) induced apoptosis by sequestering ATF2 to the cytoplasm, thereby inhibiting its transcript
275 f the c-JUN gene by recruitment of c-JUN and ATF2 to two AP-1 sites within the proximal promoter.
276 g through activating transcription factor 2 (ATF2) to the cyclic adenosine monophosphate (AMP) respon
281 expression of TIP49b efficiently attenuated ATF2 transcriptional activities under normal growth cond
282 acids 50-100 of ATF2 (ATF2(50-100)) reduces ATF2 transcriptional activities while increasing the exp
286 e transgenic mice express abnormal truncated Atf2 transcripts that may mediate a repressor effect bec
288 c-jun and activating transcription factor 2 (ATF2) upon activation by a variety of stress-based stimu
294 ite in the dp5 promoter that binds c-Jun and ATF2, which is critical for dp5 promoter induction after
295 ways are mediated through phosphorylation of ATF2, which is mediated by p38 MAPK-, JNK- and ERK-depen
297 wed that unphosphorylated JNK1beta1 bound to ATF2 with similar affinity as it did to c-Jun (K(D) = 2.
298 f JNK-dependent transcription factors (c-Jun/ATF2) with activated IRF3 in the induction of primary IR
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。